Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
SRM Entertainment's Growth Trajectory Continues with New Product Launch and Significant Reorder
-
Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report
-
Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch
-
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics
-
Unwrap the Ultimate Holiday Experience with Good Supply’s Flavour-Packed Innovations
-
Gaxos Labs Expands Capabilities with Recraft AI Integration
-
SRM Entertainment's Growth Trajectory Continues with New Product Launch and Significant Reorder
-
Safety Shot Expects Approximately 50% Revenue Growth in Q4
-
ZenaTech Launches Quantum Computing Project for Traffic Optimization and Weather Forecasting Using Drones
-
Netcompany - Transactions in connection with share buyback programme
-
Bullet Blockchain And Sailo Technologies To Join Forces Revolutionizing Bitcoin ATM Security In The U.S.
-
Kadant Hosts 2024 Investor Day
-
Alliance Witan PLC - Net Asset Value
-
Nordic Fibreboard Announces Production Resumption in January
-
Goliath Intercepts 226.12 g/t or 7.3 oz/t AuEq Over 1 Meter Within 45.60 g/t or 1.5 oz/t AuEq Over 5.95 Meters At Bonanza Zone, Surebet Discovery Remains Wide Open, Golden Triangle B.C. - Assays Are P
-
Discover the RICE (RICE COIN) Listing on XT
-
2024 Beijing Forum on "Swift Response to Public Complaints" to Take Place
-
Form 8.3 - [VOLEX PLC - 11 12 2024] - (CGWL)
-
Microchip Expands PolarFire® FPGA and SoC Solution Stacks with New Offerings for Medical Imaging and Smart Robotics
-
UnionPay International, ICBC (Macau), New Yaohan co-launch dual currency diamond card
-
Liberty Military Housing Announces Ranking Among Top 100 Largest Employee-Owned Companies for the Third Consecutive Year
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 11 12 2024] - (CGWL)
-
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
-
BexBack Exchange Launches Affiliate Program: Lifetime Earnings Opportunity for KOLs and Websites
-
Fury Highlights 2024 Milestones and Provides Outlook for the Year Ahead
-
Planting seeds for the next crop of agtech innovators - Now Recruiting Cohort 4 of the AGTECH ACCELERATOR
-
Abaxx Opens Offices in Hong Kong and Beijing
-
Zentalis Pharmaceuticals Announces Key Management Appointments
-
POET Technologies Announces US$25 Million Offering Priced at a Premium to Market
-
Lee Enterprises Reports Fourth Quarter and Full-Year FY24 results
-
CervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Dewpoint Therapeutics and ConcertAI Announce the First Phase of their Translational Oncology Partnership
-
Microbix Schedules Release of Results for Q4 Fiscal 2024
-
The Clear Communicator Awards Announces 2024 Winners
-
New Research from the Eclipse Foundation Showcases Adoption of Open Source Software in the Automotive Industry
-
Atana Named a “Hot Company to Watch in 2025” By Nucleus Research
-
InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025
-
Tilray Alternative Beverages Unveils HERB & BLOOM: A Cutting-Edge Era of Hemp-Derived Delta-9 THC Beverages
-
Xtract One Selected by Bowie State University to Strengthen Campus Security
-
Kings College NHS Trust Selects Blink Charging to Install 41 EV Chargers at Orpington's Princess Royal University Hospital
-
First Helium Licenses First of Two Wells Targeting Leduc Light Oil at Worsley
-
Tilray Alternative Beverages Unveils HERB & BLOOM: A Cutting-Edge Era of Hemp-Derived Delta-9 THC Beverages
-
CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
-
Osisko Development Receives Environmental Management Act Permits for Cariboo Gold Project
-
Kings College NHS Trust Selects Blink Charging to Install 41 EV Chargers at Orpington's Princess Royal University Hospital
-
OTC Markets Group Welcomes Rigel Resource Acquisition Corp to OTCQX
-
The Lovesac Company Reports Third Quarter Fiscal 2025 Financial Results
-
Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resis
-
Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024
-
Almaden Provides Update on Arbitration Process with Mexico
